Viewing Study NCT04750057


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2026-01-04 @ 8:43 AM
Study NCT ID: NCT04750057
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-05-06
First Post: 2021-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anifrolumab Early Access Program
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module